dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Väljaminev kiriAvalik

Response to Notifications

Sotsiaalministeerium · 8. august 2022
Viit
5.1-7/2649-1
Registreeritud
8. august 2022
Dokumendi liik
Väljaminev kiri
Adressaat
Pfizer Luxembourg SARL Eesti filiaal
Saabumis/saatmisviis
e-post
Funktsioon
5.1 Tervisekaitse, haiguste ennetamise ja tervise edendamise korraldamine
Sari
5.1-7 Ravimitootjate teavitused
Toimik
5.1-7/2022
Vastutaja
Heli Laarmann (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Rahvatervise osakond)

Failid

  • 📎Response to Notifications 5.1-7.2649-1.pdf50 KB
  • 📎Response to Notifications.docx50 KB
  • 📎Response to Notifications.pdf299 KB
  • 📎Response to Notifications_Pfizer.pdf212 KB

Sisu (failidest)

-876300 -186055 delta_recipientPersonName_1 \* MERGEFORMAT Boris Khodanovich delta_recipientName_1 \* MERGEFORMAT Pfizer Luxembourg SARL Eesti filiaal delta_recipientEmail_1 \* MERGEFORMAT [email protected] Our ref. delta_regDateTime \* MERGEFORMAT 08.08.2022 No delta_regNumber \* MERGEFORMAT 5.1-7/2649-1 delta_docName \* MERGEFORMAT Response to Notifications Ministry of Social Affairs has received following notifications of Claims for indemnity purposes from Pfizer after 15th of March 2022 (the last claim we reported as received in our letter to Pfizer No 5.1-7/1145-1; 25.03.2022): 22nd of March 2022 and 25th of March 2022 (claim received 15th of March 2022); 2nd of March 2022 (claim received 20th of January 2022); 2nd of March 2022 (claim received 12th of January 2022); 2nd of March 2022 (claim received 19th of January 2022); 4th of May 2022 (19 claims from previous period); 24th of May 2022 (17 claims from previous period). According to the notifications residents of Estonia have filed claims for losses incurred related to the administration of the COVID-19 vaccine produced by Pfizer Inc and BioNTech Manufacturing GMBH. As a response to these notification letters the Republic of Estonia via Ministry of Social Affairs states: (i) Government has not chosen an expert to evaluate the claim received. For the avoidance of doubt, with this letter the government will not renounce the right to use an expert in the future if needed. (ii) Government has agreed to indemnify Pfizer and pay the invoices of legal counsel and other expenses incurred in connection with claims in accordance with Advanced Purchase Agreement art I.12; (iii) Government agrees with the proposed notification procedure for the future indemnification claims (notification letter art (iv)). With the aim of transparency, we would propose Pfizer to compile a table with all unique claims received so far from Estonian residents. In addition , we would like to inform you that the amendment to the ravimiseadus (Medicinal Products Act) introduced compulsory vaccine damage insurance in Estonia on 1 May 2022 (hereinafter: vaccine insurance). The purpose of the amendment was to ensure compensation for health damages/ sufferings lasting for at least 4 months or if the person dies as a result of the vaccination and there is at least a probable link between the damage to health and the vaccination. The aim of establishing vaccine insurance was to increase confidence in vaccines and thereby improve people's acceptance of vaccination. The new system has created an opportunity for a person who has suffered serious health damage after vaccination to claim compensation at the rate established by law, depending on the severity of the damage. Vaccine insurance was launched on May 1, 2022, and in 2022, losses caused by COVID -19 vaccines will be reimbursed retrospectively. Claims for damages will be processed by the Estonian Health Insurance Fund (Eesti Haigekassa). As a part of mutual cooperation obligation and to minimize the number of claims taken to the court and costs related to such claims, we suggest that from now on you inform all the claimants about the opportunity to claim compensation via vaccine insurance. Please get acquainted with the procedure of failing claims for compensation after vaccination - the act is available: https://www.riigiteataja.ee/akt/129042022001. Yours sincerely, delta_signerName \* MERGEFORMAT Peep Peterson Minister of Health and Labour delta_ownerName \* MERGEFORMAT Heli Laarmann +372 delta_ownerPhone \* MERGEFORMAT 626 9129 delta_ownerEmail \* MERGEFORMAT [email protected] Boris Khodanovich Pfizer Luxembourg SARL Eesti filiaal [email protected] Our ref. 08.08.2022 No 5.1-7/2649-1 Response to Notifications Ministry of Social Affairs has received following notifications of Claims for indemnity purposes from Pfizer after 15th of March 2022 (the last claim we reported as received in our letter to Pfizer No 5.1-7/1145-1; 25.03.2022): 22nd of March 2022 and 25th of March 2022 (claim received 15th of March 2022); 2nd of March 2022 (claim received 20th of January 2022); 2nd of March 2022 (claim received 12th of January 2022); 2nd of March 2022 (claim received 19th of January 2022); 4th of May 2022 (19 claims from previous period); 24th of May 2022 (17 claims from previous period). According to the notifications residents of Estonia have filed claims for losses incurred related to the administration of the COVID-19 vaccine produced by Pfizer Inc and BioNTech Manufacturing GMBH. As a response to these notification letters the Republic of Estonia via Ministry of Social Affairs states: (i) Government has not chosen an expert to evaluate the claim received. For the avoidance of doubt, with this letter the government will not renounce the right to use an expert in the future if needed. (ii) Government has agreed to indemnify Pfizer and pay the invoices of legal counsel and other expenses incurred in connection with claims in accordance with Advanced Purchase Agreement art I.12; (iii) Government agrees with the proposed notification procedure for the future indemnification claims (notification letter art (iv)). With the aim of transparency, we would propose Pfizer to compile a table with all unique claims received so far from Estonian residents. In addition, we would like to inform you that the amendment to the ravimiseadus (Medicinal Products Act) introduced compulsory vaccine damage insurance in Estonia on 1 May 2022 (hereinafter: vaccine insurance). The purpose of the amendment was to ensure compensation for health damages/ sufferings lasting for at least 4 months or if the person dies as a result of the vaccination and there is at least a probable link between the damage to health and the vaccination. The aim of establishing vaccine insurance was to increase confidence in vaccines and thereby improve people's acceptance of vaccination. The new system has created an opportunity for a person who has suffered serious health damage after vaccination to claim compensation at the rate established by law, depending on the severity of the damage. Vaccine insurance was launched on May 1, 2022, and in 2022, Suur-Ameerika 1 / 10122 Tallinn / ESTONIA / +372 626 9301 / [email protected] / www.sm.ee / Reg. no 70001952 losses caused by COVID-19 vaccines will be reimbursed retrospectively. Claims for damages will be processed by the Estonian Health Insurance Fund (Eesti Haigekassa). As a part of mutual cooperation obligation and to minimize the number of claims taken to the court and costs related to such claims, we suggest that from now on you inform all the claimants about the opportunity to claim compensation via vaccine insurance. Please get acquainted with the procedure of failing claims for compensation after vaccination - the act is available: https://www.riigiteataja.ee/akt/129042022001. Yours sincerely, Peep Peterson Minister of Health and Labour Heli Laarmann +372 626 9129 [email protected] 2 (2)
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel